SAXAGLIPTIN HYDROCHLORIDE

Search structure
Trade Names:
Synonyms:
Status: Approved (2009)
Entry Type: Small molecule
Molecule Category: Salt
UNII: Z8J84YIX6L
Parent Compound: SAXAGLIPTIN

Structure
InChI Key TUAZNHHHYVBVBR-NHKADLRUSA-N
Smile Cl.N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2
InChI
InChI=1S/C18H25N3O2.ClH/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17;/h10-15,23H,1-7,9,20H2;1H/t10?,11?,12-,13+,14+,15-,17?,18?;/m1./s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C18H26ClN3O2
Molecular Weight 351.88
AlogP 1.16
Hydrogen Bond Acceptor 4.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 2.0
Polar Surface Area 90.35
Molecular species NEUTRAL
Aromatic Rings 0.0
Heavy Atoms 23.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Dipeptidyl peptidase IV inhibitor DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference

Related Entries

Scaffolds

Parent
Mixture
Mixture
Mixture

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Cardiac disorders
15.87
Gastrointestinal disorders
10.71
Investigations
8.05
Vascular disorders
7.9
Nervous system disorders
7.13
General disorders and administration site conditions
7.1
Metabolism and nutrition disorders
4.88
Respiratory, thoracic and mediastinal disorders
4.41
Skin and subcutaneous tissue disorders
4.17
Injury, poisoning and procedural complications
3.78
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
3.48
Renal and urinary disorders
3.3
Infections and infestations
3.13
Musculoskeletal and connective tissue disorders
3.04
Endocrine disorders
2.94
Immune system disorders
2.33
Psychiatric disorders
2.29

Cross References

Resources Reference
ChEMBL CHEMBL1201743
FDA SRS Z8J84YIX6L
PubChem 49800073
SureChEMBL SCHEMBL15152103
CONTENTS